“a slight trend”

In that study, change in anxiety and depression level was not significantly different between two groups, although there was a slight trend toward more improvement in the vinpocetine group ( p = 0.43, 0.29 respectively).

The report herein showed that there was only a slight trend for improved survival with the use of chemotherapy on univariate cox regression analysis ( P = 0.440, Table 3 ; Fig. 3 ), but the comparison was limited by the fact that the vast majority of patients (> 80%) received chemotherapy.

The mean heart rate (bpm) was 78.68 ± 15.51 ( m ± SD) for the entire sample, with a slight trend toward higher values in females (82.25 ± 9.39 m ± SD) compared to males (77.73 ± 16.77 m ± SD; p = 0.47).

When using the median (120.61 pg/ml) to divide patients in the Aachen ICI cohort , only a slight trend towards a longer PFS could be shown in patients with values below the median ( p = 0.472, Supp.Fig. 6A), so that we calculated an absolute and relative ideal cut-off (ICO) to separate patients according to PFS (cut-off sCD27:63.98 pg/ml or 2.25 × median of controls).

CDIP-58 total score was significantly improved in both the Short Flex and Long Flex groups (Short Flex mean [SE] within-treatment difference, −14.4 [2.0], P < 0.0001; Long Flex mean [SE] within-treatment difference, −12.4 [2.0], P < 0.0001) but showed a slight trend in favoring the Short Flex group (mean [SE] between-treatment change, −2.0 [2.8], P = 0.4809; Supplemental Fig. 2B).

While comparing for the percentage of patients in pediatric (< 14 years of age) and adult LGS group, who had ≥ 50%, < 50% response, no response, and worsening of seizure frequency, no significant difference was found, although there was a slight trend toward more favorable response in pediatric age group ( p = 0.49).

We found a slight trend for higher tail-generated compensatory momentum on narrow ridges (ANOVA, P <0.5; Fig. 2E,F ; Table 2 ) during the early phase of the response, whereas no effects were seen in momentum generated by body rotation.

Without tumor stroma deconvolution, patients with Ido1 high tumors showed a slight trend towards better prognosis (Fig. 5d , p = 0.55).

At 16 weeks, a slight trend (not statistically significant) towards increased ThT fluorescence was observed in BBN-treated mice compared to their control counterparts (Fig. 6 a, p = 0.5563).

2.5%, p = 1.000), though a slight trend toward reoperation was noted in the absorbable suture group (8.7% vs. 6.2%, p = 0.570).

There was a slight trend for strength improvements during the baseline phase (session coefficient=0.63, P =.57), amplified during the intervention phase (interaction=1.25, P =.25).

In a scatter plot of OSI values by duration of postoperative follow-up, there is a slight trend toward increasing OSI among AcrySof eyes ( r =0.064; P =0.572) and decreasing OSI among Tecnis eyes ( r =−0.020; P =0.857) ( Figure 7 ).

A slight trend was identified between the strength loss question and the ECOG stage ( p = 0.585).

With respect to changes of regional LBM, we observed a slight trend to more favorable trunk-LBM changes in the HIT group ( p = .635), similar changes for the lower limbs ( p = .968), and 63% higher upper limb LBM changes in the HIT group ( p = .039), indicating that LBM changes were not uniform.

Multivariate analysis in a model which included age, sex, BAP1 status, tumor stage, tumor grade, lymphatic invasion, vascular invasion, and tumor size (Table 2 ) found only a slight trend toward increased survival associated with loss of BAP1 expression, which was not statistically significant (HR 0.89; 95% CI, 0.55–1.45; P = 0.645).

Although there appears to be a slight trend of increased avian predation on eyespotted prey against less green backgrounds, this is not supported statistically (χ 2 = 0.20, df = 1, P = 0.66; Figure 3B ).

Although there was a slight trend toward higher success in females (OR = 0.818; p = 0.673), the difference was not statistically significant and may be due to chance.

Bleeding was not significantly different between conventional and rapid deployment AVR, although the pooled studies showed a slight trend toward favoring cAVR (OR: 1.08, 95% CI: [0.74, 1.59], p = .687).

Relative P‐JNK protein level was significantly upregulated in bEnd.3 cells ( F = 18.33, p = 0.0359; Figure 2A,B ) and in primary brain ECs ( F = 6.093, p = 0.0139; Figure 2E,F ) with Wnt5a stimulation, while it was just a slight trend of increase in nucleus NFAT protein expression ( F = 6.904, p = 0.6947; Figure 2A,B ).

There was a slight trend toward more women in the SHS group (47%) compared to the non-SHS non-smokers (26%; p = 0.74).

Blood glucose (Z = −1.16, p = 0.25), SOD (Z = −1.28, p = 0.21), and IBIL (Z = −0.62, p = 0.54) in SCZ patients showed a slight trend to increase and TBIL (Z = 1.76, p = 0.78) and HCY (Z = 1.39, p = 0.16) showed a slight trend to decrease after 24 weeks of risperidone treatment, but the difference was not significant.

A slight trend towards better results with fixed regimen over PRN regimen (coefficient +0.4 ETDRS letters; CI 95%: −3.0; +3.9; p=0.8), and treat and extend regimen (coefficient +2.3 ETDRS letters; CI 95%: −3.2; +7.6; p=0.4) was observed.

However, there was a slight trend in the favoring paracetamol over indomethacin in terms of primary PDA closure [RR, 1.01 (95% CI, 0.91–1.12), P = 0.88] and overall PDA closure [RR, 1.02 (95% CI, 0.94–1.11), P = 0.88] ( Table 6 ), but the difference did not reach statistical significance.

Other comparisons yielded non-significant results, with a slight trend toward higher test scores in the PTPS-free group (STAI-S: p = 0.9142; STAI-T: p = 0.4882; PSQ: p = 0.0720; PCS: p = 0.6354; HADS: p = 0.0527; HADS-anxiety: p = 0.2415).

Although the results of this meta-analysis showed no statistically significant difference, the trial arm showed a slight trend toward tumor-downstaging benefits [RR = 0.99, 95% CI (0.85, 1.15), P = 0.92].